2 Result: NYSE:AMPX
Buy-Rated: AMPX, RIVN, FDMT, CBAY, HTZ, PED - Unlocking Upside Potential
July 05th, 2023
Amprius Technologies, Inc. (NYSE: AMPX), a leading provider of advanced lithium-ion battery technology, was assumed by EF Hutton with a Buy rating and a price target of $14. With $AMPX closing at $6.98 on Monday, the assigned price target suggests. Read more
NewAmsterdam, Acrivon, Veeva Systems, Amprius Technologies: Latest Updates, Potential Upsides
June 04th, 2023
NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS) released the comprehensive findings from the ROSE2 Phase 2 clinical trial, which examined the efficacy of obicetrapib, their oral, low-dose cholesteryl ester transfer protein inhibitor, in conjunction w. Read more
Load More Content
Want To Find Some News?
News By Industries
Recent Post
-
NJCP Football League Provides Development and Opportunity for Athletes Pursuing the Next Level
March 20th, 2026March 19th, 2026How High School Graduates Can Kickstart Their Football Career
March 18th, 2026
Member Login